Phase 2 Trial of Ibrutinib and Nivolumab in Patients with Relapsed CNS Lymphomas.
Blood advances(2025)
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined